The Deal named San Francisco partner Sally Wagner Partin a “Rising Star” and profiled her in its Movers and Shakers series.
The Deal showcased Sally’s cross-border M&A practice which she focuses on life sciences, financial services and technology transactions. The profile included her representation of Swiss drug maker Roche Holding AG in its US$1.7 billion acquisition of cancer therapy company Ignyta, Inc. and its purchase of privately held ForSight VISION4 Inc., which focuses on drug delivery for treatment of retinal diseases, among deals she manages for other repeat clients. The Deal also spotlighted her various acquisitions of Israeli cybersecurity and data analytics companies. The Deal commended Sally for the fast-paced and dynamic nature of her work.
Sally represents companies in a broad range of merger and acquisition transactions involving public and private entities, strategic alliances, securities offerings and corporate governance, with a particular focus on life sciences/healthcare, financial services and technology companies.